The Mo-based polyoxometalates containing mono- and dicobalt(III) catalyst cores, [CoMo(6)O(24)H(6)](3-) and [Co(2)Mo(10)O(38)H(4)](6-), were found to serve as O(2)-evolving catalysts in a system consisting of tris(2,2'-bipyridine)ruthenium(II) (Ru(bpy)(3)(2+)) and sodium persulfate (S(2)O) in an aqueous borate buffer solution at pH 8.0. Kinetics of O(2) evolution reveals that the higher cobalt nuclearity is not necessary to attain the highly active nature of the catalyst.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: